CIK 0001133416
- Non-accelerated filer
- Smaller reporting company
GALECTIN THERAPEUTICS INC
Sign in to watch- Ticker
- GALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 043562325
- Phone
- +1 678-620-3186
- Business address
- 4960 PEACHTREE INDUSTRIAL BOULEVARD, SUITE 240, NORCROSS, GA, 30071
- Former names
- PRO PHARMACEUTICALS INC
- 4 Open-market buy Director bought 1,300 shares at $2.64 ($3,432)
- 4 Open-market buy Director bought 10,000 shares at $2.70 ($27,000)
- 4 Open-market buy Director bought 3,500 shares at $2.30 ($8,050)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4/A Open-market buy Director bought 400 shares at $2.39 ($956)
- 4 Open-market buy Director bought 400 shares at $2.39 ($956)
- 4 Open-market buy Director bought 2,500 shares at $2.38 ($5,950)
- 4 Open-market buy Director bought 1,000 shares at $3.52 ($3,520)
- 4 Open-market buy President and CEO bought 1,000 shares at $3.39 ($3,390)
- 5 Insider Annual Insider Trading Report
- 4 Open-market sale 10% owner sold 25,000 shares at $3.06 ($76,500)
- 4 Open-market buy Director bought 2,500 shares at $2.98 ($7,450)
- 4 Other acquisition Director acquired 2,063 shares (code W)
- 4 Grant or award President and CEO acquired 152,584 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 23,256 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 5 of 39 · 776 filings